P2X7 as a scavenger receptor for innate phagocytosis in the brain
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The P2X7 receptor has been widely studied for its ATP‐induced pro‐inflammatory effect, but in the absence of a ligand, P2X7 has a second function as a scavenger receptor, which is active in the development of the human brain. The scavenger activity of P2X7 is only evident in the absence of serum but is fully active in cerebrospinal fluid. P2X7 on the cell surface is present as a membrane complex, and an attachment to non‐muscle myosin of the cytoskeleton is required for particle engulfment. Selective antagonists of P2X7 pro‐inflammatory function have little effect on phagocytosis, but inheritance of a variant haplotype spanning the P2RX7 and P2RX4 genes has been associated with loss of P2X7‐mediated phagocytosis. Recent studies in mice suggest that the innate phagocytosis mediated by P2X7 receptors declines with ageing. Thus, defective P2X7‐mediated phagocytosis may contribute to age‐related neuro‐degenerative diseases including Alzheimer's disease, age‐related macular degeneration and primary progressive multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 1×
“Neuroinflammation often accompanies AD especially in its advanced stages, and this has been attributed to amyloid Aβ1–42 stimulation of microglia, which in turn increases IL-Iβ secretion (Halle et al., 2008; Heneka et al., 2013).”
BackgroundVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 2×
“Genome-wide association studies of sporadic AD have identified a cluster of AD risk genes belonging to core innate immune pathways, including CD33, CR1, MS4A6A, MS4A4E, ABCA7 and TREM2 (Hollingworth et al., 2011; Jonsson et al., 2013).”
BackgroundThe NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · cited 1×
“Our data support the use of P2X7 antagonists for neurodegenerative diseases, in which the neuropathological features are accompanied by an inflammatory response (Heppner et al., 2015).”
MethodInitiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · cited 2×
“Genome-wide association studies of sporadic AD have identified a cluster of AD risk genes belonging to core innate immune pathways, including CD33, CR1, MS4A6A, MS4A4E, ABCA7 and TREM2 (Hollingworth et al., 2011; Jonsson et al., 2013).”
BackgroundA polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Impairment of paravascular clearance pathways in the aging brain
Kress, B. T., Iliff, J. J., Xia, M., Wang, M., Wei, H. S., Zeppenfeld, D., Xie, L., Kang, H., Xu, Q., Liew, J. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24271 · Cited by 1,521 · cited 1×
“Besides apoptotic cells, protein clearance in the brain is also impaired by 40% in old mice, accompanied by a decline in CSF-interstitial fluid exchange (Kress et al., 2014), which could directly lead to an accumulation of damaged and misfolded proteins, impairing cell function and tissue homeostasis (Vilchez et al.”
BackgroundAutoimmune Disease and Impaired Uptake of Apoptotic Cells in MFG-E8-Deficient Mice
Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyama, Y., & Nagata, S. (2004) · Science · doi:10.1126/science.1094359 · Cited by 992 · cited 1×
“Among the scavenger receptors implicated in the phagocytosis of neurones destined for removal are milk fat globule EGF factor 8 (Hanayama et al., 2004), TAM receptor tyrosine kinases,Mer andAxl (Duncan et al.”
BackgroundJay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142322 · Cited by 682 · cited 1×
“Variants of these genes, especially TREM2 and CD33, are associated with compromised phagocytic function of monocytes/macrophages and amyloid Aβ accumulation in AD brains (Bradshaw et al., 2013; Jay et al., 2015).”
BackgroundAge-related myelin degradation burdens the clearance function of microglia during aging
Safaiyan, S., Kannaiyan, N., Snaidero, N., Brioschi, S., Biber, K., Yona, S., Edinger, A. L., Jung, S., Rossner, M. J., & Simons, M. (2016) · Nature Neuroscience · doi:10.1038/nn.4325 · Cited by 604
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: g protein-coupled receptors
Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Marrion, N. V., Peters, J. A., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13878 · Cited by 588
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Initiative, T. A. D. N., Bradshaw, E. M., Chibnik, L. B., Keenan, B. T., Ottoboni, L., Raj, T., Tang, A., Rosenkrantz, L. L., Imboywa, S., Lee, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3435 · Cited by 570 · cited 1×
“Variants of these genes, especially TREM2 and CD33, are associated with compromised phagocytic function of monocytes/macrophages and amyloid Aβ accumulation in AD brains (Bradshaw et al., 2013; Jay et al., 2015).”
BackgroundQu, Y., Franchi, L., Nunez, G., & Dubyak, G. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1913 · Cited by 563
Liaisons dangereuses: P2X7 and the inflammasome
Di Virgilio, F. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.07.002 · Cited by 493 · cited 1×
“…of the P2X7 channel/pore by ATP leads to K+ efflux, an effect that activates the assembly of the NALP3 inflammasome (also called NLRP3) and secretion of IL-1α and IL-1β as well as IL-18 (Sluyter et al., 2004; Mariathasan et al., 2006; Di Virgilio, 2007; Pizzirani et al., 2007; Qu et al., 2007).”
BackgroundThe P2X 7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X 7 R Pore
Monif, M., Reid, C. A., Powell, K. L., Smart, M. L., & Williams, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5512-08.2009 · Cited by 374 · cited 1×
“In the presence of serum, the trophic effects of the P2X7 receptor pore has also been reported in cultures of rat microglia (Monif et al., 2009), although the same group later found that such trophic effects may be due to IL-1β release, which also is mediated by the P2X7 pore formation (Monif et al.”
BackgroundActivation of Microglia by Amyloid β Requires P2X7 Receptor Expression
Sanz, J. M., Chiozzi, P., Ferrari, D., Colaianna, M., Idzko, M., Falzoni, S., Fellin, R., Trabace, L., & Di Virgilio, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803612 · Cited by 293 · cited 1×
“Agonists for P2X7 receptors are known to activate a pathway to NLRP3, and Sanz and others have shown that the presence of P2X7 on microglia is required for the activation of microglia by Aβ (Rampe et al., 2004; Sanz et al., 2009).”
BackgroundMcLarnon, J. G., Ryu, J. K., Walker, D. G., & Choi, H. B. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240470.97295.d3 · Cited by 281
Reanalysis of P2X7Receptor Expression in Rodent Brain
Sim, J. A., Young, M. T., Sung, H.-Y., North, R. A., & Surprenant, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-04.2004 · Cited by 264 · cited 1×
“Emerging evidence, both functional and genetic, now points to an important scavenger role of an archaic purinergic receptor, P2X7, within the CNS in which P2X7 was found expressed in brain macrophages, microglia, astrocytes, oligodendrocytes, new born rat and human embryonic brain neurones but not adult cortical neuro…”
BackgroundNucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
Fowler, B. J., Gelfand, B. D., Kim, Y., Kerur, N., Tarallo, V., Hirano, Y., Amarnath, S., Fowler, D. H., Radwan, M., Young, M. T., et al. (2014) · Science · doi:10.1126/science.1261754 · Cited by 225 · cited 8×
“Ambati’s group has shown that the P2X7 receptor plays a critical role in Alu RNA transcripts-induced NLRP3 inflammasome activation in both mouse models of geographical atrophy (GA, also known as the ‘dry’ type of advanced AMD) and choroidal neovascularization (CNV, also known as the ‘wet’ type of late AMD) (Fowler et…”
BackgroundInfluentialThe microglial ATP‐gated ion channel P2X7 as a CNS drug target
Bhattacharya, A., & Biber, K. (2016) · Glia · doi:10.1002/glia.23001 · Cited by 221 · cited 4×
“Antagonists of pro-inflammatory P2X7 pore formation There are now a number of selective P2X7 antagonists of different chemical classes which at nanomolar concentrations inhibit pro-inflammatory P2X7 pore formation (Bhattacharya and Biber, 2016).”
BackgroundInfluentialBlock of purinergic P2X7 receptor is neuroprotective in an animal model of Alzheimer's disease
Ryu, J. K., & McLarnon, J. G. (2008) · NeuroReport · doi:10.1097/wnr.0b013e3283179333 · Cited by 134 · cited 1×
“…of P2X7mediated pro-inflammatory response by antagonists has been proven beneficial in a number of neurodegenerative diseases including AD (Ryu and McLarnon, 2008; DiazHernandez et al., 2012; Chen et al., 2014b), MS (Matute et al., 2007), ischaemic stroke (Arbeloa et al., 2012; Bindra et…”
BackgroundApolloni, S., Amadio, S., Montilli, C., Volonte, C., & D'Ambrosi, N. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt259 · Cited by 109 · cited 2×
“model of ALS, the clinical onset was significantly anticipated and the disease progression worsened in both male and female P2X7 / /SOD1-G93A mice (Apolloni et al., 2013).”
BackgroundMarcellino, D., Suárez-Boomgaard, D., Sánchez-Reina, M. D., Aguirre, J. A., Yoshitake, T., Yoshitake, S., Hagman, B., Kehr, J., Agnati, L. F., Fuxe, K., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0400-0 · Cited by 97 · cited 1×
“…et al., 2015; Zhao et al., 2016), amyotrophic lateral sclerosis (ALS) (Apolloni et al., 2014; Bartlett et al., 2017; Cervetto et al., 2013; Parisi et al., 2016) and Parkinson’s disease (Carmo et al., 2014; Ferrazoli et al., 2017; Kumar et al., 2017; Marcellino et al., 2010; Wang et al., 2017).”
BackgroundZhao, H., Zhang, X., Dai, Z., Feng, Y., Li, Q., Zhang, J. H., Liu, X., Chen, Y., & Feng, H. (2016) · Scientific Reports · doi:10.1038/srep23286 · Cited by 84 · cited 1×
“, 2004), traumatic brain injury (Wang et al., 2015; Zhao et al., 2016), amyotrophic lateral sclerosis (ALS) (Apolloni et al.”
BackgroundMertk drives myosin II redistribution during retinal pigment epithelial phagocytosis
Strick, D. J., Feng, W., & Vollrath, D. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3058 · Cited by 81 · cited 1×
“In line with our findings, others have shown that MERTK (Mer), a TAM scavenger receptor, forms a complex with NMMHC-IIA and participates in the daily ingestion of photoreceptor outer segment discs by retinal pigment epithelium (RPE), as RPE treated with blebbistatin or myosin II siRNA exhibited a significant phagocyti…”
Background
Cited by
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
Role of P2X7 Receptors in Immune Responses During Neurodegeneration
Oliveira-Giacomelli, Á., Petiz, L. L., Andrejew, R., Turrini, N., Silva, J. B., Sack, U., & Ulrich, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662935 · Cited by 68
Pleiotropic Roles of P2X7 in the Central Nervous System
Kanellopoulos, J. M., & Delarasse, C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00401 · Cited by 48
“In the absence of ATP, it was clearly established that P2X7 acts as a scavenger receptor conferring phagocytic properties to murine peritoneal macrophages, human monocytes, macrophages and microglia in the absence of serum (Gu et al., 2011; Gu and Wiley, 2018; Janks et al., 2018).”
Background
Metadata
- Authors
- Gu, B. J., & Wiley, J. S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2018-10-05
- Volume
- 175
- Issue
- 22
- Pages
- 4195-4208
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2885180395
- Cited by
- 74
- References
- 27
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.